title: ACP journal club. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs.
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Pastores
authors.forename: Maria T
authors.initials: MT
authors.lastname: DeSancho
mesh_terms: D000925:Anticoagulants / Q000191:economics*; D016638:Critical Illness / Q000191:economics*; D017985:Dalteparin / Q000191:economics*; D005260:Female; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006493:Heparin / Q000191:economics*; D006801:Humans; D008297:Male; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin; D017985:Dalteparin